DarshanTalks Podcast
Welcome to DarshanTalks!
We demystify fraud for legal, regulatory, and compliance essentials in the life sciences and pharmacy industries. Through engaging 15-30-minute interviews with influential change makers, short educational regulatory defbriefs, and 60 second audio takeaways, we unveil the strategies behind bringing drugs and devices to market—and keeping them there!
Powered By The Kulkarni Law Firm - Helping regulators see your business the way you do.
We focus on life science issues involving medical affairs, marketing and advertising, and clinical research so that you can learn about the industry, enhance your business and grow your career.
DarshanTalks Podcast
AI-Powered Engagement is a Minefield
AI voice tech might be the next big privacy risk for pharma marketers, and lawsuits are already in motion. In this episode of Darshan Talks, we dive into the legal challenges surrounding AI-powered voice tools in healthcare marketing, especially under California’s strict privacy laws.
A federal court ruling in Ambrose v. Google suggests that recording conversations without explicit real-time consent may be illegal. This could impact pharma companies using AI voice assistants, Alexa skills, voice bots, and patient support apps. If your tech processes speech without proper disclosures, you might be violating the California Invasion of Privacy Act (CIPA)—a law with $5,000 in statutory damages per violation.
For large pharma brands, non-compliance could lead to multimillion-dollar class action lawsuits. Burying consent deep in a privacy policy won’t cut it anymore—courts are demanding clear, real-time disclosure. To stay ahead, pharma marketers must audit their tech stack, collaborate with privacy law experts, and push vendors to meet compliance standards.
The future of pharma marketing is controversial, and the brands that innovate responsibly will thrive. Contact the Kulkarni Law Firm to audit your voice marketing stack before the lawsuits start piling up.
